We are live on ! Find out more
Corient Private Wealth

Corient Private Wealth Portfolio holdings

AUM $69.9B
1-Year Est. Return 22.19%
This Fund
S&P 500
This Quarter Est. Return
+9.83%
1 Year Est. Return
+22.19%
3 Year Est. Return
+69.97%
5 Year Est. Return
10 Year Est. Return
AUM
$56.2B
AUM Growth
+$1.8B
Cap. Flow
+$5.21B
Cap. Flow %
9.28%
Top 10 Hldgs %
21.35%
Holding
2,399
New
146
Increased
921
Reduced
1,050
Closed
123

Sector Composition

Rank Sector Weight
1 Technology 19.64%
2 Healthcare 11.07%
3 Financials 10.51%
4 Industrials 7.72%
5 Consumer Discretionary 7.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UGL icon
1726
ProShares Ultra Gold
UGL
$650M
$412K ﹤0.01%
22,800
-440
-2% -$7K
RSPF icon
1727
Invesco S&P 500 Equal Weight Financials ETF
RSPF
$304M
$409K ﹤0.01%
6,372
ANF icon
1728
Abercrombie & Fitch
ANF
$4.17B
$409K ﹤0.01%
3,263
-112
-3% -$12.8K
EET icon
1729
ProShares Ultra MSCI Emerging Markets
EET
$34.8M
$408K ﹤0.01%
7,937
AQST icon
1730
Aquestive Therapeutics
AQST
$462M
$408K ﹤0.01%
95,813
-95,813
-50% -$319K
CABO icon
1731
Cable One
CABO
$213M
$407K ﹤0.01%
962
-303
-24% -$149K
DUSA icon
1732
Davis Select US Equity ETF
DUSA
$1.25B
$407K ﹤0.01%
10,070
GT icon
1733
Goodyear
GT
$2.07B
$406K ﹤0.01%
29,648
+6,595
+29% +$86.3K
GBCI icon
1734
Glacier Bancorp
GBCI
$6.55B
$405K ﹤0.01%
10,067
-344
-3% -$13.3K
ADT icon
1735
ADT
ADT
$5.16B
$405K ﹤0.01%
60,306
-27,067
-31% -$180K
MTRN icon
1736
Materion
MTRN
$5.01B
$405K ﹤0.01%
+3,071
New +$389K
BURL icon
1737
Burlington
BURL
$22B
$404K ﹤0.01%
1,739
-298
-15% -$60.8K
CC icon
1738
Chemours
CC
$2.59B
$404K ﹤0.01%
15,374
-4,630
-23% -$132K
HTGC icon
1739
Hercules Capital
HTGC
$2.94B
$403K ﹤0.01%
21,821
+8,605
+65% +$153K
BMRN icon
1740
BioMarin Pharmaceuticals
BMRN
$11.5B
$402K ﹤0.01%
4,608
+109
+2% +$9.76K
RBLX icon
1741
Roblox
RBLX
$34B
$402K ﹤0.01%
10,517
+492
+5% +$20K
MAN icon
1742
ManpowerGroup
MAN
$2.39B
$401K ﹤0.01%
5,168
-5,532
-52% -$412K
FDN icon
1743
First Trust Dow Jones Internet Index Fund ETF
FDN
$4.86B
$401K ﹤0.01%
1,953
+10
+0.5% +$1.97K
XPO icon
1744
XPO
XPO
$25B
$399K ﹤0.01%
3,270
-4,225
-56% -$452K
ONEQ icon
1745
Fidelity Nasdaq Composite Index ETF
ONEQ
$10.2B
$398K ﹤0.01%
6,187
+200
+3% +$12.4K
OTTR icon
1746
Otter Tail
OTTR
$3.88B
$397K ﹤0.01%
4,593
-248
-5% -$21.6K
PKW icon
1747
Invesco BuyBack Achievers ETF
PKW
$1.69B
$396K ﹤0.01%
3,663
-372
-9% -$37.8K
TRN icon
1748
Trinity Industries
TRN
$2.97B
$396K ﹤0.01%
14,234
-994
-7% -$25.6K
BYD icon
1749
Boyd Gaming
BYD
$6.47B
$396K ﹤0.01%
5,877
+1,328
+29% +$84.7K
ACCD
1750
DELISTED
Accolade Inc
ACCD
$396K ﹤0.01%
37,746
-25,356
-40% -$288K

Similar funds

Corient Private Wealth's Q1 2024 Portfolio in Review

As of Q1 2024, Corient Private Wealth held 2,399 positions worth $56.2B, up 3.3% from $54.4B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Corient Private Wealth deployed $5.21B of net new capital in Q1 2024, opening 146 new positions and adding to 921 existing holdings. Its largest new stake was iShares iBonds Dec 2028 Term Corporate ETF: 693,322 shares worth $17.3M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Apple, an estimated $165M trimmed.

  • Corient Private Wealth's largest Q1 2024 buy was iShares iBonds Dec 2028 Term Corporate ETF: 693,322 shares worth $17.3M.
  • Corient Private Wealth added most to Berkshire Hathaway Class A in Q1 2024, an estimated $5.82B increase.
  • Corient Private Wealth's biggest Q1 2024 reduction was Apple, cutting an estimated $165M.
  • Corient Private Wealth fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $21.7M.
  • Corient Private Wealth's ten largest holdings make up 21% of its $56.2B portfolio in Q1 2024.
  • Corient Private Wealth opened 146 new positions and closed 123 in Q1 2024.
  • Corient Private Wealth's portfolio value rose 3.3% quarter-over-quarter to $56.2B.

Based on Corient Private Wealth's 13F filing for Q1 2024, filed 9 May 2024.